Hey there, time traveller!
This article was published 12/3/2007 (4862 days ago), so information in it may no longer be current.
What she didn't expect was to be diagnosed with an aggressive form of colon cancer only a month later.
The tumour has since spread to her liver and her lungs, and Arnot has had three surgeries to remove parts of the tumour to keep the disease at bay.
But when she was recently denied access to the pricey drug Avastin, Arnot began wondering why some colon cancer patients are given the chance to live longer while others aren't.
"I strongly believe in equal access to treatment," she said. "Not only does it extend life, it gives (patients) a better quality of life."
Avastin is a drug used in combination with chemotherapy that has been clinically proven to extend survival for aggressive colon and lung cancer. It costs $50,000 for a course of treatment, and blocks tumour growth and spread by cutting off the tumour's blood and oxygen supply.
Manitoba Health gives funding to CancerCare Manitoba, which then administers cancer treatment to patients and decides which drugs to fund -- including pricey new treatments like Avastin.
CancerCare CEO Dr. Dhali Dhaliwal said since aggressive colon cancer is always fatal, oncologists have prescribed Avastin for few patients.
On average, patients with aggressive colon cancer will die within two years if they continue chemotherapy or nine months if they discontinue all treatment.
Avastin will extend life by about four months for the average patient, but Dhaliwal said cancer agencies can't afford to spend $50,000 for terminal patients. He said CancerCare has to weigh how to best spend its limited funds, and developing screening programs to detect the disease before it spreads will help save more lives.
Giving every colon cancer patient Avastin would cost about $7 million a year, compared to the $3-million cost of a provincial colon cancer screening program.
If caught early, colon cancer is treatable.
Each year in Manitoba, about 780 people are diagnosed with colon cancer and half will die.
Nearly four years after her initial diagnosis, Arnot is still battling cancer. Although she had a brief remission for six months, the tumour continued to grow and she had part of a lung removed last year.
Arnot now has chemotherapy every three weeks.
While she still doesn't understand why she can't have Avastin, Arnot said she wants everyone over 50 to know to get tested for the disease.
This spring, CancerCare is mailing 20,000 colon cancer screening kits to Manitobans age 50 to 74. They expect it could reduce the number of people who die from the disease by as much as 20 per cent.
"We need to educate people so that they don't end up with the same problems as I have," Arnot said.
Your support has enabled us to provide free access to stories about COVID-19 because we believe everyone deserves trusted and critical information during the pandemic.
Our readership has contributed additional funding to give Free Press online subscriptions to those that can’t afford one in these extraordinary times — giving new readers the opportunity to see beyond the headlines and connect with other stories about their community.
To those who have made donations, thank you.
To those able to give and share our journalism with others, please Pay it Forward.
The Free Press has shared COVID-19 stories free of charge because we believe everyone deserves access to trusted and critical information during the pandemic.
While we stand by this decision, it has undoubtedly affected our bottom line.
After nearly 150 years of reporting on our city, we don’t want to stop any time soon. With your support, we’ll be able to forge ahead with our journalistic mission.
If you believe in an independent, transparent, and democratic press, please consider subscribing today.
We understand that some readers cannot afford a subscription during these difficult times and invite them to apply for a free digital subscription through our Pay it Forward program.